Compare ANIP & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | INOD |
|---|---|---|
| Founded | 2001 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | N/A | 1993 |
| Metric | ANIP | INOD |
|---|---|---|
| Price | $80.23 | $52.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $102.14 | $91.67 |
| AVG Volume (30 Days) | 417.1K | ★ 1.0M |
| Earning Date | 11-07-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.46 |
| EPS | ★ 1.67 | 1.01 |
| Revenue | ★ $826,880,000.00 | $238,467,000.00 |
| Revenue This Year | $43.41 | $48.85 |
| Revenue Next Year | $9.66 | $25.93 |
| P/E Ratio | ★ $48.00 | $51.90 |
| Revenue Growth | 48.87 | ★ 73.57 |
| 52 Week Low | $52.50 | $26.41 |
| 52 Week High | $99.50 | $93.85 |
| Indicator | ANIP | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 34.84 | 36.15 |
| Support Level | $80.30 | $53.39 |
| Resistance Level | $83.60 | $59.38 |
| Average True Range (ATR) | 2.33 | 2.78 |
| MACD | 0.17 | 0.20 |
| Stochastic Oscillator | 25.86 | 10.93 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.